How can the blood transfusion medicine community contribute to public health in tough economic times?

Journal of Infectious Diseases

Volumn 205, Issue 6, 2012, Pages 867-869

  Katz, Louis M ^a  

^a Mississippi Valley Regional Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASYMPTOMATIC DISEASE; BLOOD DONOR; BLOOD EXAMINATION; BLOOD TRANSFUSION; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; HEALTH ECONOMICS; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLUENZA A (H1N1); MURINE LEUKEMIA VIRUS; NONHUMAN; NOTE; NUCLEIC ACID ANALYSIS; PATIENT SAFETY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SEROLOGY; VIREMIA;

ANIMALS; BLOOD DONORS; FEMALE; GENETIC VARIATION; GENOME, VIRAL; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; RNA, VIRAL; VIREMIA;

EID: 84857566697     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir866     Document Type: Note

References (11)

1. Whitaker BI, Schlumpf K, Schulman J, Green J. Report of the US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health, 2011.
2. Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, Norris PJ. National Heart, Lung, Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II). Influenza viremia and the potential for blood-borne transmission. Transfusion 2007;47:1080-8.
3. Stramer SL, Collins C, Nugent T, et al. Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors. J Infect Dis 2012;205; 886-94.
4. Delwart EL, Slikas E, Kamel H, et al. HIV, HCV, and HBV genetic diversity in US blood donors. J Infect Dis 2012;205; 875-85.
5. Busch MP, Glynn SA. Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen Repository. J Infect Dis 2009;199:1564-6.
6. Shurin SB. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities. Blood 2011;118:5380-2.
7. Lombardi VC, Ruscetti FW, Das Gupta J, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009;326:585-9.
8. Simmons G, Glynn SA, Holmberg JA, et al. Blood XMRV Scientific Research Working Group. The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans. Transfusion 2011;51:643-53.
9. Simmons G, Glynn SA, Komaroff AL, et al. Blood XMRV Scientific Research Working Group (SRWG). Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 2011;33:814-17.
10. Paprotka T, Delviks-Frankenberry KA, Cingöz O, et al. Recombinant origin of the retrovirus XMRV. Science 2011;333:97-101.
11. Hohn O, Bannert N. Origin of XMRV and its demise as a human pathogen associated with chronic fatigue syndrome. Viruses 2011;8:1312-19.